Novartis tries texts to track supplies; China says 13% of capsulemakers were cheating;

> China's State Food and Drug Administration (SFDA) reports that 254 drug capsulemakers it inspected, which represent 12.7% of the industry, were manufacturing capsules that didn't meet standards. Story

> Novartis ($NVS) is leading a supply chain program in Tanzania that uses text messages to help manage malaria drug supplies in public health facilities. Item

> The manufacturers of two dozen drugs that failed quality tests by the Karnataka Drug Control Department in India have been ordered to make changes to their manufacturing. Story

> AptarGroup ($ATR) is buying Stelmi Group, which makes elastomer primary packaging components for injectable drug delivery. Release

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.